HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 20.277

Change

-0.71 (-3.39)%

Market Cap

USD 0.03B

Volume

588.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.93%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-7.15 (-1.51%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.66 (-1.38%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.33 (-1.06%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.56 (-0.23%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.45 (-2.11%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.86 (-0.93%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.79 (-1.65%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.57%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.60 (-0.80%)

USD 5.54B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.67% 35% F 34% F
Dividend Return 0.99% 65% D 46% F
Total Return -12.69% 41% F 38% F
Trailing 12 Months  
Capital Gain -4.53% 53% F 60% D-
Dividend Return 3.32% 66% D+ 58% F
Total Return -1.22% 62% D 65% D
Trailing 5 Years  
Capital Gain 57.92% 62% D 69% C-
Dividend Return 17.03% 63% D 51% F
Total Return 74.95% 75% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain 11.94% 68% D+ 70% C-
Dividend Return N/A 2% F 51% F
Total Return N/A 12% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) N/A 94% A 52% F
Risk Adjusted Return N/A 2% F 50% F
Market Capitalization 0.03B 10% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.